PRE 14C

PRELIMINARY INFORMATION STATEMENT

Company: Inhibitor Therapeutics, Inc.
Filed: October 3, 2014
Period of Report: October 3, 2014
Accession Number: 0001193125-14-363354

View Document ↗ View on SEC.gov ↗